AntifungalClick on antimicrobial name to see wild type MIC distributions |
Species-related breakpoints (S</R>) | Non-species related breakpointsA S</R> | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Candida albicans |
Candida glabrata |
Candida krusei |
Candida parapsilosis |
Candida tropicalis |
|||||||
| Fluconazole | RD | 2/4 | IE | -- | 2/4 | 2/4 | 2/4 | ||||
| Voriconazole | RD | 0.125/0.125B | IE | -- | 0.125/0.125B | 0.125/0.125B | IE | ||||
|
| Version* | Date | Action |
| 2.1 | 2008-08-27 | Voriconazole Rationale Document by the EUCAST Subcommittee on Antifungal Susceptiubility Testing (EUCAST AFST) published on EUCAST website |
| 2.0 | 2008-07-24 | Voriconazole breakpoints as determined by the EUCAST Subcommittee on Antifungal Susceptiubility Testing (EUCAST AFST) made publicly available |
| 1.0 | 2007-07-10 | Fluconazole breakpoints as determined by the EUCAST Subcommittee on Antifungal Susceptiubility Testing (EUCAST AFST) made publicly available |